JP2022510736A5 - - Google Patents
Info
- Publication number
- JP2022510736A5 JP2022510736A5 JP2021554804A JP2021554804A JP2022510736A5 JP 2022510736 A5 JP2022510736 A5 JP 2022510736A5 JP 2021554804 A JP2021554804 A JP 2021554804A JP 2021554804 A JP2021554804 A JP 2021554804A JP 2022510736 A5 JP2022510736 A5 JP 2022510736A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- ring
- substituted
- atom
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024102161A JP2024123202A (ja) | 2018-12-05 | 2024-06-25 | 大環状化合物とその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018228234 | 2018-12-05 | ||
| JP2018228234 | 2018-12-05 | ||
| PCT/JP2019/048593 WO2020116660A1 (en) | 2018-12-05 | 2019-12-04 | Macrocyclic compound and use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102161A Division JP2024123202A (ja) | 2018-12-05 | 2024-06-25 | 大環状化合物とその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022510736A JP2022510736A (ja) | 2022-01-27 |
| JP2022510736A5 true JP2022510736A5 (cg-RX-API-DMAC7.html) | 2022-11-30 |
| JP7895177B2 JP7895177B2 (ja) | 2026-07-27 |
Family
ID=70975488
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021554804A Active JP7895177B2 (ja) | 2018-12-05 | 2019-12-04 | 大環状化合物とその使用 |
| JP2024102161A Pending JP2024123202A (ja) | 2018-12-05 | 2024-06-25 | 大環状化合物とその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102161A Pending JP2024123202A (ja) | 2018-12-05 | 2024-06-25 | 大環状化合物とその使用 |
Country Status (18)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20210030A1 (ar) | 2018-08-20 | 2021-02-16 | Janssen Pharmaceutica Nv | مثبطات تفاعل البروتين-بروتين KEAP1-Nrf2 |
| CN114174289B (zh) | 2019-05-31 | 2025-03-07 | Ube株式会社 | 苯并三唑衍生物 |
| BR112023004567A2 (pt) * | 2020-09-14 | 2023-04-04 | Sanofi Sa | Derivados de tetrahidroisoquinolina para o tratamento de doenças do sangue e doenças inflamatórias |
| AU2024251986A1 (en) * | 2023-04-03 | 2025-10-16 | Acelink Therapeutics, Inc. | Novel compounds and uses thereof |
| CN119707895B (zh) * | 2023-12-18 | 2026-03-31 | 江苏苏中药业研究院有限公司 | 一种7-甲酰基-2,3-二氢苯并呋喃-4-碳腈的制备方法 |
| WO2026026967A1 (zh) * | 2024-08-02 | 2026-02-05 | 劲方医药科技(上海)股份有限公司 | 丙烯酰基类化合物及其用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103270022B (zh) | 2010-08-31 | 2015-08-19 | 巴勃罗·比咯斯拉达 | 神经营养蛋白受体激动剂及其作为药物的应用 |
| KR102322794B1 (ko) | 2013-06-21 | 2021-11-05 | 카리오팜 쎄라퓨틱스, 인코포레이티드 | 핵수송 조절인자 및 이의 용도 |
| ES2784244T3 (es) | 2013-12-18 | 2020-09-23 | Glaxosmithkline Ip Dev Ltd | Reguladores de Nrf2 |
| LT3307739T (lt) | 2015-06-15 | 2021-03-10 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 reguliatoriai |
| KR20180017038A (ko) | 2015-06-15 | 2018-02-20 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Nrf2 조절제 |
| AU2016280236B2 (en) | 2015-06-15 | 2019-02-07 | Astex Therapeutics Limited | Nrf2 regulators |
| WO2017026516A1 (ja) | 2015-08-12 | 2017-02-16 | 持田製薬株式会社 | イソチアゾール誘導体 |
| US10364256B2 (en) | 2015-10-06 | 2019-07-30 | Glaxosmithkline Intellectual Property Development Limited | Biaryl pyrazoles as NRF2 regulators |
| US10351530B2 (en) | 2015-10-06 | 2019-07-16 | Glaxosmithkline Intellectual Property Development Limited | Arylcyclohexyl pyrazoles as NRF2 regulators |
| WO2018109641A1 (en) | 2016-12-12 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | 3-carboxylic acid pyrroles as nrf2 regulators |
| WO2018109642A1 (en) | 2016-12-12 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | N-aryl pyrazoles as nrf2 regulators |
| ES2901617T3 (es) | 2016-12-14 | 2022-03-23 | Glaxosmithkline Ip Dev Ltd | Bisarilamidas como reguladores de NRF2 |
| EP3555068B1 (en) | 2016-12-14 | 2020-12-02 | GlaxoSmithKline Intellectual Property Development Limited | 3-oxo-1,4-diazepinyle compounds as nrf2 activators |
| JP2020502123A (ja) | 2016-12-14 | 2020-01-23 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | Nrf2アクチベーターとしてのビスアリール複素環 |
| JP2020502152A (ja) | 2016-12-15 | 2020-01-23 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | Nrf2アクチベーターとしてのエーテル結合トリアゾール |
| AU2017376900A1 (en) | 2016-12-15 | 2019-05-23 | Glaxosmithkline Intellectual Property Development Limited | NRF2 compounds |
| AR110590A1 (es) | 2016-12-27 | 2019-04-10 | Biogen Ma Inc | Activador de nrf2 |
| EP3573963B1 (en) | 2017-01-30 | 2021-09-01 | Biogen MA Inc. | Nrf2 activator |
| US20190389836A1 (en) * | 2017-01-30 | 2019-12-26 | Biogen Ma Inc. | Nrf2 activator |
| JP2020097526A (ja) * | 2017-03-28 | 2020-06-25 | 武田薬品工業株式会社 | 複素環化合物 |
-
2019
- 2019-12-04 UA UAA202102856A patent/UA127872C2/uk unknown
- 2019-12-04 KR KR1020217020790A patent/KR102919982B1/ko active Active
- 2019-12-04 BR BR112021010704-5A patent/BR112021010704A2/pt unknown
- 2019-12-04 AR ARP190103549A patent/AR117251A1/es unknown
- 2019-12-04 CN CN201980080214.5A patent/CN113164468A/zh active Pending
- 2019-12-04 US US17/299,659 patent/US11518763B2/en active Active
- 2019-12-04 CA CA3121952A patent/CA3121952C/en active Active
- 2019-12-04 NZ NZ776102A patent/NZ776102A/en unknown
- 2019-12-04 JP JP2021554804A patent/JP7895177B2/ja active Active
- 2019-12-04 TW TW108144324A patent/TWI820266B/zh active
- 2019-12-04 MX MX2021006527A patent/MX2021006527A/es unknown
- 2019-12-04 WO PCT/JP2019/048593 patent/WO2020116660A1/en not_active Ceased
- 2019-12-04 EP EP19892751.9A patent/EP3890738A4/en active Pending
- 2019-12-04 AU AU2019391942A patent/AU2019391942B2/en active Active
- 2019-12-04 SG SG11202105125XA patent/SG11202105125XA/en unknown
-
2021
- 2021-05-31 PH PH12021551262A patent/PH12021551262A1/en unknown
- 2021-06-02 CL CL2021001451A patent/CL2021001451A1/es unknown
- 2021-06-03 CO CONC2021/0007304A patent/CO2021007304A2/es unknown
-
2024
- 2024-06-25 JP JP2024102161A patent/JP2024123202A/ja active Pending